Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Sioux Falls, SD
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
El Paso, TX
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Houston, TX
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Humble, TX
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Humble, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Midland, TX
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Midland, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Norfolk, VA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
mi
from
Buenos Aires,
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Norwich, CT
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Norwich, CT
Click here to add this to my saved trials
Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
Screening Evaluation for Studies of COPD
Status: Enrolling
Updated:  3/8/2018
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
Screening Evaluation for Studies of COPD
Status: Enrolling
Updated: 3/8/2018
Johns Hopkins Asthma and Allergy Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Clinical Research of West Florida
mi
from
Clearwater, FL
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
American Health Research Inc.
mi
from
Charlotte, NC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
American Health Research Inc.
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
North Carolina Clinical Research
mi
from
Raleigh, NC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
North Carolina Clinical Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Palmetto Medical Research Associates
mi
from
Easley, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Palmetto Medical Research Associates
mi
from
Easley, SC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Greenville Pharmaceutical Research
mi
from
Greenville, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Greenville Pharmaceutical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Upstate Pharmaceutical Research
mi
from
Greenville, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Upstate Pharmaceutical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
S. Carolina
mi
from
Spartanburg, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
S. Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
Spartanburg Medical Research
mi
from
Spartanburg, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated:  3/12/2018
CU Pharmaceutical Research
mi
from
Union, SC
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 3/12/2018
CU Pharmaceutical Research
mi
from
Union, SC
Click here to add this to my saved trials
Evaluation of COPD Co-Pilot
Evaluation of COPD Co-Pilot
Status: Enrolling
Updated:  3/12/2018
Medical University of South Carolina
mi
from
Charleston, SC
Evaluation of COPD Co-Pilot
Evaluation of COPD Co-Pilot
Status: Enrolling
Updated: 3/12/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization
Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization
Status: Enrolling
Updated:  3/19/2018
Temple University Hospital
mi
from
Philadelphia, PA
Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization
Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization
Status: Enrolling
Updated: 3/19/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated:  3/21/2018
Mereo Investigator Site
mi
from
Michigan City, IN
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated: 3/21/2018
Mereo Investigator Site
mi
from
Michigan City, IN
Click here to add this to my saved trials
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated:  3/21/2018
Mereo Research Site
mi
from
Baltimore, MD
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated: 3/21/2018
Mereo Research Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated:  3/21/2018
Mereo Research Site
mi
from
Milwaukee, WI
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated: 3/21/2018
Mereo Research Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated:  3/21/2018
Mereo Research Site
mi
from
Dupnitsa,
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults
Status: Enrolling
Updated: 3/21/2018
Mereo Research Site
mi
from
Dupnitsa,
Click here to add this to my saved trials
Harmonica Playing Improves Quality of Life in Patients With COPD
Harmonica Playing Improves Inspiratory and Expiratory Muscle Strength, Reduces Shortness of Breath With Activity, and Improves Quality of Life in Patients With COPD
Status: Enrolling
Updated:  3/21/2018
Baylor University Medical Center
mi
from
Dallas, TX
Harmonica Playing Improves Quality of Life in Patients With COPD
Harmonica Playing Improves Inspiratory and Expiratory Muscle Strength, Reduces Shortness of Breath With Activity, and Improves Quality of Life in Patients With COPD
Status: Enrolling
Updated: 3/21/2018
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
A Single Center Study to Measure the Bronchodilator Effect of Albuterol Sulfate or Albuterol Sulfate/Ipratropium Bromide Using the Pneuma Respiratory Inhaler and the ProAir HFA Inhaler in Stable COPD Patients
Status: Enrolling
Updated:  3/26/2018
Advanced Respiratory and Sleep Medicine, PLLC
mi
from
Hickory, NC
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
A Single Center Study to Measure the Bronchodilator Effect of Albuterol Sulfate or Albuterol Sulfate/Ipratropium Bromide Using the Pneuma Respiratory Inhaler and the ProAir HFA Inhaler in Stable COPD Patients
Status: Enrolling
Updated: 3/26/2018
Advanced Respiratory and Sleep Medicine, PLLC
mi
from
Hickory, NC
Click here to add this to my saved trials
Evaluation of COPD Co-Pilot
Evaluation of COPD Co-Pilot
Status: Enrolling
Updated:  3/28/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Evaluation of COPD Co-Pilot
Evaluation of COPD Co-Pilot
Status: Enrolling
Updated: 3/28/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigator Site
mi
from
Birmingham, AL
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Fullerton, CA
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Fullerton, CA
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigator Site
mi
from
Clearwater, FL
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigator Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Port Orange, FL
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Normal, IL
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Normal, IL
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Shelby, NC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Shelby, NC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Medford, OR
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Simpsonville, SC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Simpsonville, SC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Spartanburg, SC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Union, SC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Union, SC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Waterbury, CT
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Waterbury, CT
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Huntersville, NC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Huntersville, NC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Lodz,
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Lodz,
Click here to add this to my saved trials
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Status: Enrolling
Updated:  4/18/2018
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Status: Enrolling
Updated: 4/18/2018
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Tolerance and Acute Effects of Humidified Nasal High-flow With Oxygen (HNHF-O2) on Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD
Status: Enrolling
Updated:  4/18/2018
Temple University Hospital
mi
from
Philadelphia, PA
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Tolerance and Acute Effects of Humidified Nasal High-flow With Oxygen (HNHF-O2) on Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD
Status: Enrolling
Updated: 4/18/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  4/30/2018
GSK Investigational Site
mi
from
Charleston, SC
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 4/30/2018
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  4/30/2018
GSK Investigational Site
mi
from
Richmond, VA
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 4/30/2018
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  4/30/2018
GSK Investigational Site
mi
from
Morgantown, WV
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 52 Week Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 125mcg Once-daily Alone and in Combination With GW642444 25mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 4/30/2018
GSK Investigational Site
mi
from
Morgantown, WV
Click here to add this to my saved trials